A myocyte enhancer factor 2 (MEF2) site located in a hypersensitive region of the FGF16 gene locus is required for preferential promoter activity in neonatal cardiac myocytes

DNA and Cell Biology

Volumn 27, Issue 4, 2008, Pages 173-182

  Sofronescu, Alina G ^a   Jin, Yan ^a   Cattini, Peter A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; FIBROBLAST GROWTH FACTOR 16; MYOCYTE ENHANCER FACTOR 2;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING SITE; CODON; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE TRANSFER; HEART MUSCLE CELL; HYBRID GENE; MOUSE; NONHUMAN; NUCLEASE PROTECTION ASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; RAT; REPORTER GENE; TRANSCRIPTION INITIATION SITE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHROMATIN; DEOXYRIBONUCLEASE I; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY; MICE; MICE, TRANSGENIC; MUTATION; MYOCARDIUM; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT PROTEINS; TRANSFECTION;

MURINAE; MUS MUSCULUS; RATTUS;

EID: 42149182413     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0689     Document Type: Article

References (32)

1. Akazawa, H., and Komuro, I. (2003). Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92, 1079-1088.
2. Antoine, M., Wirz, W., Tag, C.G., Gressner, A.M., Wycislo, M., Muller, R., and Kiefer, P. (2006). Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun 346, 224-233.
3. Antoine, M., Wirz, W., Tag, C.G., Mavituna, M., Emans, N., Korff, T., Stoldt, V., Gressner, A.M., and Kiefer, P. (2005). Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23, 87-95.
4. Black, B.L., and Olson, E.N. (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14, 167-196.
5. Colvin, J.S., White, A.C., Pratt, S.J., and Ornitz, D.M. (2001). Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128, 2095-2106.
6. Cserjesi, P., Lilly, B., Hinkley, C., Perry, M., and Olson, E.N. (1994). Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J Biol Chem 269, 16740-16745.
7. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11, 1475-1489.
8. Doble, B.W., Chen, Y., Bosc, D.G., Litchfield, D.W., and Kardami, E. (1996). Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 79, 647-658.
9. Doble, B.W., Ping, P., and Kardami, E. (2000). The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 86, 293-301.
10. Evans, S.M. (1999). Vertebrate tinman homologues and cardiac differentiation. Semin Cell Dev Biol 10, 73-83.
11. Huang, W.Y., and Liew, C.C. (1997). A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac alpha-myosin heavy chain gene. Biochem J 325 (Pt 1), 47-51.
12. Itoh, N., and Ornitz, D.M. (2004). Evolution of the Fgf and Fgfr gene families. Trends Genet 20, 563-569.
13. Jackowski, G., and Liew, C.C. (1980). Fractionation of rat ventricular nuclei. Biochem J 188, 363-373.
14. Jeffers, M., Shimkets, R., Prayaga, S., Boldog, F., Yang, M., Burgess, C., Fernandes, E., Rittman, B., Shimkets, J., LaRochelle, W.J., and Lichenstein, H.S. (2001). Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. Cancer Res 61, 3131-3138.
15. Jin, Y., Surabhi, R.M., Fresnoza, A., Lytras, A., and Cattini, P.A. (1999). A role for A=T-rich sequences and Pit-1=GHF-1 in a distal enhancer located in the human growth hormone locus control region with preferential pituitary activity in culture and transgenic mice. Mol Endocrinol 13, 1249-1266.
16. Katoh, M. (2005). Comparative genomics on mammalian Fgf3-Fgf4 locus. Int J Oncol 27, 281-285.
17. Lavine, K.J., Yu, K., White, A.C., Zhang, X., Smith, C., Partanen, J., and Ornitz, D.M. (2005). Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8, 85-95.
18. Lee, Y., Nadal-Ginard, B., Mahdavi, V., and Izumo, S. (1997). Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol Cell Biol 17, 2745-2755.
19. Lytras, A., Surabhi, R.M., Zhang, J.F., Jin, Y., and Cattini, P.A. (1996). "Repair" of the chorionic somatomammotropin-A "enhancer" region reveals a novel functional element in the chorionic somatomammotropin-B enhancer. Mol Cell Endocrinol 119, 1-10.
20. Madiai, F., and Hackshaw, K. (2002). Expression of the mouse FGF-1 and FGF-1.A mRNAs during embryonic development and in the aging heart. Res Commun Mol Pathol Pharmacol 112, 139-144.
21. McBride, K., and Nemer, M. (2001). Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription. Can J Physiol Pharmacol 79, 673-681.
22. Miyake, A., Konishi, M., Martin, F.H., Hernday, N.A., Ozaki, K., Yamamoto, S., Mikami, T., Arakawa, T., and Itoh, N. (1998). Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem Biophys Res Commun 243, 148-152.
23. Miyamoto, M., Naruo, K., Seko, C., Matsumoto, S., Kondo, T., and Kurokawa, T. (1993). Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13, 4251-4259.
24. Ohmachi, S., Watanabe, Y., Mikami, T., Kusu, N., Ibi, T., Akaike, A., and Itoh, N. (2000). FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun 277, 355-360.
25. Ornitz, D.M., and Itoh, N. (2001). Fibroblast growth factors. Genome Biol 2, REVIEWS3005.
26. Pasumarthi, K.B., Jin, Y., and Cattini, P.A. (1997). Cloning of the rat fibroblast growth factor-2 promoter region and its response to mitogenic stimuli in glioma C6 cells. J Neurochem 68, 898-908.
27. Schug, J., Schuller, W.P., Kappen, C., Salbaum, J.M., Bucan, M., and Stoeckert, C.J., Jr. (2005). Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol 6, R33.
28. Shibata, F., Baird, A., and Florkiewicz, R.Z. (1991). Functional characterization of the human basic fibroblast growth factor gene promoter. Growth Factors 4, 277-287.
29. Sontag, D.P. (2005). Characterization of fibroblast growth factor-16 expression and biological function in the heart. Ph.D. Thesis: University of Manitoba, Winnipeg, Canada, 220 pp.
30. Sontag, D.P., and Cattini, P.A. (2003). Cloning and bacterial expression of postnatal mouse heart FGF-16. Mol Cell Biochem 242, 65-70.
31. Whitelaw, C.B., Harris, S., McClenaghan, M., Simons, J.P., and Clark, A.J. (1992). Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice. Biochem J 286 (Pt 1), 31-39.
32. Wright, T.J., Hatch, E.P., Karabagli, H., Karabagli, P., Schoenwolf, G.C., and Mansour, S.L. (2003). Expression of mouse fibroblast growth factor and fibroblast growth factor receptor genes during early inner ear development. Dev Dyn 228, 267-272.